Executive Summary of JSMM Clinical Practice Guidelines for Diagnosis and Treatment of Cryptococcosis 2019-Reference-Cited by-同舟云学术

Executive Summary of JSMM Clinical Practice Guidelines for Diagnosis and Treatment of Cryptococcosis 2019

Published:2020 Issue:4 Volume:61 Page:61-89
ISSN:2185-6486
Container-title:Medical Mycology Journal
language:en
Short-container-title:Medical Mycology Journal

Author:

Izumikawa Koichi¹,Kakeya Hiroshi²,Sakai Fumikazu³,Shibuya Kazutoshi⁴,Sugita Takashi⁵,Takazono Takahiro¹,Takata Tohru⁶,Tashiro Masato¹,Teruya Katsuji⁷,Nakamura Shigeki⁸⁹,Noguchi Hiromitsu¹⁰,Hiruma Masataro¹¹,Makimura Koichi¹²,Miyazaki Taiga¹,Miyazaki Yoshitsugu⁸,Yamagishi Yuka¹³,Yoshida Koichiro¹⁴,Watanabe Akira¹⁵

Affiliation:

1. Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences

2. Department of Infection Control Science, Osaka City University Graduate School of Medicine

3. Department of Diagnostic Radiology, Saitama Medical University International Medical Center

4. Department of Pathology, Omori Hospital, Toho University School of Medicine

5. Department of Microbiology, Meiji Pharmaceutical University

6. Department Oncology, Hematology, and Infectious Diseases, Fukuoka University Hospital

7. AIDS Clinical Center, National Center for Global Health and Medicine

8. Department of Chemotherapy and Mycoses, National Institute of Infectious Diseases

9. Department of Microbiology, Tokyo Medical University

10. Noguchi Dermatology Clinic

11. Ochanomizu Institute for Medical Mycology and Allergology

12. Medical Mycology, Graduate School of Medicine, Teikyo University

13. Department of Clinical Infectious Diseases, Aichi Medical University Graduate School of Medicine

14. Department of Medical Safety Management, Division of Infection Control and Prevention, Kindai University Hospital

15. Division of Clinical Research, Medical Mycology Research Center, Chiba University

Publisher

The Japanese Society for Medical Mycology

Subject

Infectious Diseases,Microbiology

Link

https://www.jstage.jst.go.jp/article/mmj/61/4/61_20.001/_pdf

Reference37 articles.

1. 8.Q1 3) Kohno S, Kakeya H, Izumikawa K, Miyazaki T, Yamamoto Y,Yanagihara K, Mitsutake K, Miyazaki Y, Maesaki S, YasuokaA, Tashiro T, Mine M, Uetani M, Ashizawa K: Clinical featureof pulmonary cryptococcosis in non-HIV patients in Japan.J Infect Chemother 21: 23-30, 2015.

2. 8.Q1 4) Maziarz EK, Perfect JR: Cryptococcosis. Infect Dis Clin N Am 30: 179-206, 2016.

3. 8.Q1 5) Stamm AM, Polt SS: False-negative cryptococcal antigentest. JAMA 244: 1359, 1980.

4. 8.Q1 6) Tintelnot K, Hagan F, Han CO, Seibold M, Rickerts V, Boekhout T: Pitfalls in serological diagnosis of Cryptococcus gattii infections. Med Mycol 53: 874-879, 2015.

5. 8.Q1 7) Westerink MAJ, Amsterdam D, Petell RJ, Stram MN, Apicella MA: Septicemia due to DF-2: Cause of false-positive cryptococcal latex agglutination result. Am J Med 83: 155-158, 1987.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Criptococoma intestinal associado a abdome agudo obstrutivo: relato de caso;STUDIES IN HEALTH SCIENCES;2024-09-05

2. Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM;The Lancet Infectious Diseases;2024-08

3. 全身性エリテマトーデス治療中に致死的経過を辿った播種性クリプトコックス症の1例;Kansenshogaku Zasshi;2023-05-20

4. A Case of Laryngeal Cryptococcosis that Responded to Itraconazole;Case Reports in Otolaryngology;2023-04-12

5. Lesion size as a prognostic factor in the antifungal treatment of pulmonary cryptococcosis: a retrospective study with chest CT pictorial review of 2-year follow up;BMC Infectious Diseases;2023-03-14